Fırat Ersan(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI)0000-0001-5337-0169
İzel Günay(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI)0009-0007-5650-5998
Gülsen Sener(Sağlık Bilimleri Üniversitesi Başakşehir Çam ve Sakura Şehir Hastanesi Biyokimya Bilim Dalı)0000-0002-2006-2175
İbrahim Polat(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI)0000-0002-1418-634X
Nilüfer Çetinkaya(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI)0000-0001-9183-3558
Objective & Hypothesis:Objective: This study aims to assess Bisphenol-A levels in serum samples from preeclampsia patients and determine potential distinctions by comparing them against samples from healthy pregnant women Material-Methods: This single-center prospective case-control study aimed to investigate the potential differences in serum Bisphenol-A (BPA) levels between pregnant patients diagnosed with preeclampsia and healthy pregnant women.
📊
Key Findings & Data:The study encompassed two distinct groups: the study group consisted of 30 pregnant patients diagnosed with preeclampsia, while the control group included 30 healthy pregnant women matched in terms of gestational weeks and demographic characteristics, maintaining a 1:1 ratio.
💡
Conclusion & Impact:Further research is needed in this area
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bisphenol A · Preeclampsia · Pregnancy
Abstract
Objective: This study aims to assess Bisphenol-A levels in serum samples from preeclampsia patients and determine potential distinctions by comparing them against samples from healthy pregnant women Material-Methods: This single-center prospective case-control study aimed to investigate the potential differences in serum Bisphenol-A (BPA) levels between pregnant patients diagnosed with preeclampsia and healthy pregnant women. The study encompassed two distinct groups: the study group consisted of 30 pregnant patients diagnosed with preeclampsia, while the control group included 30 healthy pregnant women matched in terms of gestational weeks and demographic characteristics, maintaining a 1:1 ratio. Serum samples were subjected to analysis using a BPA ELISA kit Results: The study encompassed a total of 60 patients, who were categorized into two groups: preeclampsia (n=30) and control (n=30). Upon comparison of the BPA values between the two groups, no statistically significant difference was detected (p=0.579). Conclusion: Clear-cut scientific evidence establishing a conclusive causal link between BPA and preeclampsia is still lacking. Further research is needed in this area
Talmaç, M. A., Ersan, F., Günay, İ., Sener, G., Polat, İ., Çetinkaya, N. (2023). Maternal Bisphenol a Levels in Patients Diagnosed with Preeclampsia: A Case-Control Study. New Trends in Medicine Sciences, Volume: 4 Issue: Supplemental Issue. https://doi.org/10.56766/ntms.1344747
Jung E, Romero R, Yeo L ve ark. The etiology of preeclampsia. Am J Obstet Gynecol. 2022; 226(2s):S844-s66.
Erçal T. Şiddetli preeklampsi ve eklampsi: hastane öncesi tani ve yönetimde güncel yaklaşimlar. Hastane Öncesi Dergisi. 2019; 4(1):33-46.
Cimmino I, Fiory F, Perruolo G ve ark. Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease. Int J Mol Sci. 2020; 21(16).
Vom Saal FS, Nagel SC, Coe BL et al. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol. 2012; 354(1-2):74-84.
Ehrlich S, Lambers D, Baccarelli A et al. Endocrine Disruptors: A Potential Risk Factor for Gestational Diabetes Mellitus. Am J Perinatol. 2016; 33(13):1313-18.
den Braver-Sewradj SP, van Spronsen R, Hessel EVS. Substitution of bisphenol A: a review of the carcinogenicity, reproductive toxicity, and endocrine disruption potential of alternative substances. Crit Rev Toxicol. 2020; 50(2):128-47.
Wang ZY, Lu J, Zhang YZ ve ark. Effect of Bisphenol A on invasion ability of human trophoblastic cell line BeWo. Int J Clin Exp Pathol. 2015; 8(11):14355-64.
Zhang YF, Shan C, Wang Y et al. Cardiovascular toxicity and mechanism of bisphenol A and emerging risk of bisphenol S. Sci Total Environ. 2020; 723:137952.
Arita Y, Park HJ, Cantillon A et al. Effect of bisphenol-A (BPA) on placental biomarkers for inflammation, neurodevelopment and oxidative stress. J Perinat Med. 2019; 47(7):741-49.
D'Angelo S, Scafuro M, Meccariello R. BPA and Nutraceuticals, Simultaneous Effects on Endocrine Functions. Endocr Metab Immune Disord Drug Targets. 2019; 19(5):594-604.
Wehbe Z, Nasser SA, El-Yazbi A ve ark. Estrogen and Bisphenol A in Hypertension. Curr Hypertens Rep. 2020; 22(3):23.
Camara LR, Arbuckle TE, Trottier H et al. Associations between Maternal Exposure to Bisphenol A or Triclosan and Gestational Hypertension and Preeclampsia: The MIREC Study. Am J Perinatol. 2019; 36(11):1127-35.
Dagdeviren G, Arslan B, Keles A et al. The evaluation of serum bisphenol A in patients with preeclampsia. J Obstet Gynaecol Res. 2023; 49(5):1322-27.
Leclerc F, Dubois MF, Aris A. Maternal, placental and fetal exposure to bisphenol A in women with and without preeclampsia. Hypertens Pregnancy. 2014; 33(3):341-48.